Thousand Oaks Biopharmaceuticals
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A Chinese biotech developing novel biologic therapies for oncology and immunology using advanced antibody engineering.
OncologyImmunology
Technology Platform
An integrated antibody discovery and protein engineering platform for developing monoclonal, bispecific, and conjugated antibodies.
Opportunities
Capitalizing on China's large oncology market and regulatory reforms to accelerate biologic drug development and approval.
Risk Factors
High clinical development costs and the risk of pipeline candidates failing in later-stage trials against established competitors.
Competitive Landscape
Faces intense competition from global biologics leaders like Roche and Amgen, as well as a surge of innovative antibody-focused biotechs in China.